Verve Therapeutics
@vervetx
ID: 1075455552652754944
19-12-2018 18:19:19
601 Tweet
5,5K Takipçi
257 Takip Edilen
The first patient has been dosed with VERVE-101, a once-and-done CRISPR base editing medicine designed to permanently lower LDL and help treat heart attack! Hear from our CEO Sek Kathiresan MD as he discusses this milestone. Read full announcement here: ir.vervetx.com/news-releases/…